Antianginal effects of YM430, a novel calcium entry-blocking and beta-adrenoceptor-blocking agent in several experimental angina models.

1. We evaluated the antianginal effects of YM430 in several experimental models in vitro and in vivo. 2. In isolated dog coronary artery, YM430 (10(-8)-10(-6) M) inhibited 3,4-diaminopyridine-induced rhythmic contractions with an IC50 value of 59.2 nM. 3. In anesthetized rats, YM430 (10-100 mg/kg PO) inhibited arginine vasopressin-induced ST-segment depression with an IC50 value of 36.6 mg/kg PO. 4. In anesthetized dogs, YM430 (0.3 mg/kg IV) significantly inhibited ST-segment elevation induced by coronary artery occlusion. 5. These findings suggest that YM430 may be of value in the treatment of various types of angina pectoris such as variant and stable angina.
AuthorsK Shibasaki, Y Arai, W Uchida, T Okazaki, M Asano, T Takenaka
JournalGeneral pharmacology (Gen Pharmacol) Vol. 29 Issue 4 Pg. 545-50 (Oct 1997) ISSN: 0306-3623 [Print] ENGLAND
PMID9352300 (Publication Type: Journal Article)
Chemical References
  • Adrenergic beta-Antagonists
  • Calcium Channel Blockers
  • YM 430
  • Propranolol
  • 4-Aminopyridine
  • Nifedipine
  • 3,4-diaminopyridine
  • 4-Aminopyridine (analogs & derivatives, pharmacology)
  • Adrenergic beta-Antagonists (pharmacology)
  • Angina Pectoris (drug therapy, physiopathology)
  • Animals
  • Calcium Channel Blockers (pharmacology)
  • Coronary Disease (physiopathology)
  • Coronary Vasospasm (physiopathology)
  • Coronary Vessels (drug effects)
  • Dogs
  • Electrocardiography (drug effects)
  • Female
  • In Vitro Techniques
  • Male
  • Muscle Contraction (drug effects)
  • Muscle, Smooth, Vascular (drug effects)
  • Myocardial Ischemia (physiopathology)
  • Nifedipine (analogs & derivatives, pharmacology, therapeutic use)
  • Propranolol (pharmacology)
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: